๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Systemic hormone and chemotherapy in the treatment of skeletal metastases

โœ Scribed by P. Reichardt

Book ID
105742319
Publisher
Springer-Verlag
Year
1998
Tongue
German
Weight
216 KB
Volume
27
Category
Article
ISSN
0085-4530

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The role of systemic chemotherapy in the
The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer
โœ Francesco Grossi; Tindaro Scolaro; Lucia Tixi; Maura Loprevite; Andrea Ardizzoni ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 73 KB

Brain is the most common site of metastatic spread in small-cell lung cancer (SCLC). Approximately 10% of SCLC patients have brain metastases (BM) already at diagnosis and an additional 40% will develop central nervous system (CNS) involvement during their disease course. Although whole brain radiot

Cost-effectiveness of systemic and regio
Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases
โœ Isabelle Durand-Zaleski; Sally Earlam; Carol Fordy; Michael Davies; Timothy G. A ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB ๐Ÿ‘ 3 views

## Background: Management of unresectable colorectal liver metastases (clm) can be by regional (hepatic arterial infusion [hai]) or systemic chemotherapy, or by symptom control alone. in this study the costs of each type of management were related to clinical outcome in 134 patients with clm. ## M